Foresite Capital logo

Foresite Capital

North America, California, United States, San Francisco

Description

Foresite Capital is a healthcare and life sciences investment firm.

Investor Profile

Foresite Capital has made 164 investments, with 19 in the past 12 months and 26% as lead.

Stage Focus

  • Series B (34%)
  • Series C (25%)
  • Series A (13%)
  • Post Ipo Equity (9%)
  • Series D (9%)
  • Series E (3%)
  • Series Unknown (2%)
  • Private Equity (1%)
  • Series F (1%)
  • Seed (1%)

Country Focus

  • United States (88%)
  • United Kingdom (7%)
  • Switzerland (2%)
  • Australia (1%)
  • Canada (1%)
  • Isle of Man (1%)
  • Hong Kong (1%)
  • China (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Life Science
  • Pharmaceutical
  • Biopharma
  • Genetics
  • Health Diagnostics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Foresite Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 34
CA
North America, Massachusetts, United States, Boston
Co-Investments: 22
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 23
Casdin Capital
North America, New York, United States, New York
Co-Investments: 21
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 22
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 26
The Column Group
North America, California, United States, San Francisco
Co-Investments: 14
Venrock
North America, California, United States, Palo Alto
Co-Investments: 22
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 19
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 26

Which angels does Foresite Capital often collaborate with?

AG
North America, New Jersey, United States, New Brunswick
Shared Deals: 1
BG
North America, Washington, United States, Seattle
Shared Deals: 1
RK
North America, California, United States
Shared Deals: 2
BN
North America, Massachusetts, United States, Boston
Shared Deals: 1
VW
North America, Florida, United States, Miami Beach
Shared Deals: 1
MA
North America, California, United States, San Francisco
Shared Deals: 2
CS
North America, California, United States, Truckee
Shared Deals: 1
AW
North America, California, United States, San Francisco
Shared Deals: 2
AF
North America, California, United States, Los Angeles
Shared Deals: 1
SA
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Foresite Capital?

Latigo Biotherapeutics

Thousand Oaks, California, United States

Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.

BiotechnologyHealth CareMedicalTherapeutics
Series BMar 17, 2025
Amount Raised: $150,000,000
Eikon Therapeutics

Hayward, California, United States

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

BiotechnologyHealth CareLife ScienceMedical
Series DFeb 26, 2025
Amount Raised: $350,700,000
Abcuro

Newton, Massachusetts, United States

Abcuro develops immunotherapies to treat autoimmunity and cancer.

BiotechnologyHealth CareMedicalTherapeutics
Series CFeb 12, 2025
Amount Raised: $200,000,000
Ikena Oncology

Boston, Massachusetts, United States

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

BiotechnologyHealth CareHealth DiagnosticsOncologyTherapeutics
Post Ipo EquityDec 23, 2024
Amount Raised: $75,000,000
Rapt Therapeutics

South San Francisco, California, United States

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Post Ipo EquityDec 23, 2024
Amount Raised: $150,000,000
Pleno

San Diego, California, United States

Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.

BiopharmaBiotechnologyHealth CareHealth Diagnostics
Series BDec 12, 2024
Amount Raised: $25,000,000
Sollis Health

New York, New York, United States

Sollis Health offers concierge medical centers that provide on-demand care for families, including same-day visits and virtual care options.

Health CareHealth DiagnosticsMedicalPersonal Health
Series BDec 5, 2024
Amount Raised: $33,000,000
Avenzo Therapeutics

San Diego, California, United States

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series ANov 18, 2024
Chimagen Biosciences

Chengdu, Sichuan, China

Chimagen Biosciences is a company that is creating a novel class of multi-functional monoclonal antibodies for cancer therapy.

BiotechnologyHealth CareMedical
Series BOct 31, 2024
Seaport Therapeutics

Boston, Massachusetts, United States

Seaport Therapeutics operates as a clinical stage biopharmaceutical company.

BiotechnologyPharmaceuticalTherapeutics
Series BOct 21, 2024
Amount Raised: $225,000,000